Literature DB >> 11976014

Ocular tolerance of preservatives and alternatives.

Pascal Furrer1, Joachim M Mayer, Robert Gurny.   

Abstract

Eye drops are multiple dosage forms protected against microbial contamination by means of preservatives. However, the ocular tolerance of these chemicals can vary and this may result in adverse toxic or allergic reactions. This overview presents the pharmacopoeial requirements for the preservation of eye drops, the factors affecting ocular tolerance as well as the adverse external ocular effects induced by preservatives. The alternatives to the use of preservatives are also discussed, including the recent progress in eye drops packaging.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976014     DOI: 10.1016/s0939-6411(01)00246-6

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  26 in total

1.  Bioavailability of fluorescein from a new drug delivery system in human eyes.

Authors:  A Steinfeld; A Lux; S Maier; R Süverkrüp; M Diestelhorst
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

2.  Cytotoxicity assays of new artificial tears containing 2-methacryloyloxyethyl phosphorylcholine polymer for ocular surface cells.

Authors:  Masahiko Ayaki; Atsuo Iwasawa; Yoshimi Niwano
Journal:  Jpn J Ophthalmol       Date:  2011-08-10       Impact factor: 2.447

Review 3.  The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.

Authors:  Gerd Geerling; Joseph Tauber; Christophe Baudouin; Eiki Goto; Yukihiro Matsumoto; Terrence O'Brien; Maurizio Rolando; Kazuo Tsubota; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

4.  Potential toxicity of topical ocular solutions.

Authors:  Nevio Cimolai
Journal:  CMAJ       Date:  2019-08-12       Impact factor: 8.262

Review 5.  Artificial tears potpourri: a literature review.

Authors:  Majid Moshirfar; Kasey Pierson; Kamalani Hanamaikai; Luis Santiago-Caban; Valliammai Muthappan; Samuel F Passi
Journal:  Clin Ophthalmol       Date:  2014-07-31

Review 6.  PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.

Authors:  Mihaela Cristina Coroi; Simona Bungau; Mirela Tit
Journal:  Rom J Ophthalmol       Date:  2015 Jan-Mar

7.  New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations.

Authors:  Dörte von Deylen; Christina Dreher; Oliver Seidelmann; Stephan Reichl
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

8.  Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells.

Authors:  Luís F Neves; Jinghua Duan; Adrienne Voelker; Anil Khanal; Lacey McNally; Jill Steinbach-Rankins; Brian P Ceresa
Journal:  J Microencapsul       Date:  2016-08-10       Impact factor: 3.142

9.  An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite.

Authors:  David Granet; Steven J Lichtenstein; Bruce Onofrey; James A Katz
Journal:  Clin Ophthalmol       Date:  2007-12

10.  Analysis of the effects of preservative-free tafluprost on the tear proteome.

Authors:  Sebastian Funke; Sabine Beck; Katrin Lorenz; Marion Kotterer; Dominik Wolters; Natarajan Perumal; Norbert Pfeiffer; Franz H Grus
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.